IL-19-/- mice have a decreased inflammatory response to a T cell-dependent challenge of the airways. by Carol Hoffman (196241)

Normalized whole brain volume change over 5 years using an SPM pipeline. by Renxin Chu (5169857)

Identification of regions of interest to perform ligations between blood vessels. by Pablo Castro-Córdova (5614352)

Loss of Lsd1 in long bone mesenchymal cells disrupts growth plate organization but not collagen maturation. by Petri Rummukainen (4247122)

“…<p>(A) Growth plates of Lsd1 knockout mice have decreased organization and thicker hypertrophic zone (right) compared to control (left) (n = 4–5 per group). …”

Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival. by Kyle C. Kloepping (9928265)

“…<p>(A) A375 and (B) MeWo melanoma cells were treated with 0.5 μM 5-, 8-, 10-, 12-,14-, or 16-TPP for 24 h, 48 h, or 72 h and analyzed for cell viability by the MTT method (* significant relative to control; p<0.05; N = 4). …”

NIF significantly decreases diabetes-induced leukostasis in the retinal vasculature. by Alexander A. Veenstra (474665)

Nicotine decreased Akt phosphorylation in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Visualization and quantification of adhered and internalized <i>C</i>. <i>difficile</i> spores in the ileum and colonic mucosa during aging. by Pablo Castro-Córdova (5614352)

IL-17A inhibits apoptosis of OCPs. by Hao Tang (44155)

Breathing Rate decreases over time during prolonged anesthesia. by Lucie A. Low (328214)

BACE1 and Aβ levels are not correlated with nimodipine levels in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

MVEC viability is decreased over time in PEG-based hydrogels. by Rebecca A. Scott (488956)

Loss of Lsd1 in long bone mesenchymal cells leads to impaired ossification and growth. by Petri Rummukainen (4247122)

“…<p>(A) Lsd1 knockout mice have decreased body weight and length of tibia. …”

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

(R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

(R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”

Move persistence estimates (γ_t) from the best-supported move persistence mixed-effects model fitted to Fastloc GPS location data from 22 naïve grey seal pups interpolate... by Benia V. R. Nowak (17054285)

Deletion of TXNIP decreases thioredoxin levels under hyperoxic conditions. by Mohammed A. Abdelsaid (287140)

“…<p>WT and TKO mice were subjected to 5 days hyperoxia (p7–12). Retinas were collected for protein and mRNA levels of thioredoxin (cytoplasmic Trx-1) (<b>A</b>) as well as mitochondrial Trx-2 (<b>B</b>) and total thioredoxin protein (<b>C</b>). …”

Legend for supporting information S2–S5. by Birgit Deboutte (19452787)

TGF-β decreases LPL mRNA expression in macrophages by Scott A. Irvine (26973)